Search Results - I. Lowy

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma by J. Kaczmar, K. Papadopoulos, G. Ansstas, A. Birnbaum, J. Mehnert, O. Hamid, B. Hughes, G. Rabinowits, A. Wei, M. Yushak, J. Mani, F. Fang, J. Wang, G. Kroog, M. Salvati, I. Lowy, M. Fury, N.J. Lakhani

    Published in EJC Skin Cancer (2024-01-01)
    Get full text
    Article


  2. 2

    Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress by S. Bhatia, D. Davar, S. Thomas, A.W. Silk, R.C. Wu, R. Ladwa, S.J. Park, C.M. Kelly, D.J. Wong, J. Grewal, N. Vohra, A.M. Lim, J. Puegero, C. Verschraegen, B. Zhong, I. Lowy, M. Fury, M. Cristea

    Published in EJC Skin Cancer (2024-01-01)
    Get full text
    Article


Search Tools: